Stocks Health care PRME
NASDAQ · Health carePrime Medicine, Inc. (PRME)
It posted a net loss of $187.9M. In fiscal 2025 capital spending exceeded operating cash flow by $167.1M. At June 30, 2026 it held $47.5M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
What Prime Medicine, Inc. does
Prime Medicine, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker PRME.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $4.6M | -$201.1M | -$1.35 | -$167.1M |
| 2024 | $3M | -$195.9M | -$1.65 | -$130.2M |
| 2023 | $0 | -$198.1M | -$2.18 | -$174.1M |
| 2022 | $0 | -$121.8M | -$4.19 | -$147.9M |
| 2022 | $0 | -$165.4M | -$14.19 | -$38.2M |
| 2020 | $5.2M | -$3.4M | -$1.91 | -$6.2M |
Latest SEC filings
What Prime Medicine, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026
- August 6, 2026
- July 8, 2026Other event 8-K
- June 8, 2026
- May 7, 2026Quarterly report 10-Q · period to March 31, 2026
- May 7, 2026
- April 23, 2026
- April 23, 2026Additional proxy material DEFA14A
- April 23, 2026Proxy statement DEF 14A
- April 16, 2026
Questions about PRME
What does Prime Medicine, Inc. do?
Prime Medicine, Inc. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker PRME.
Is Prime Medicine, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $187.9M.
When did Prime Medicine, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026.
Similar companies
Follow PRME
Get an email when Prime Medicine, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow PRME: get an email when it filesWhere the numbers come from
Financial figures are the values Prime Medicine, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.